What are the DSM‑5 criteria for hypochondriasis (Illness Anxiety Disorder)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

DSM-5 Criteria for Illness Anxiety Disorder (Formerly Hypochondriasis)

In DSM-5, hypochondriasis was eliminated and replaced by two distinct diagnoses: Illness Anxiety Disorder (IAD) and Somatic Symptom Disorder (SSD), with the key distinction being the presence or absence of significant somatic symptoms. 1, 2, 3

Core Diagnostic Criteria for Illness Anxiety Disorder

Criterion A: Preoccupation with Having or Acquiring a Serious Illness

  • The patient exhibits excessive preoccupation with having or acquiring a serious medical illness, despite minimal or absent somatic symptoms. 4, 3
  • This preoccupation must be excessive and recurrent, representing pathological health anxiety rather than normative health concerns. 5

Criterion B: High Level of Health Anxiety

  • The individual demonstrates a high level of anxiety about health, with heightened alarm about personal health status. 2, 3
  • This anxiety is disproportionate to any actual medical risk or objective findings. 4

Criterion C: Excessive Health-Related Behaviors or Maladaptive Avoidance

  • The patient engages in excessive health-related behaviors (e.g., repeatedly checking body for signs of illness, excessive medical consultations, reassurance-seeking). 6, 3
  • OR exhibits maladaptive avoidance (e.g., avoiding medical appointments, hospitals, or health-related information). 6
  • Research demonstrates that avoidance is a valid behavioral construct, with more severely avoidant patients showing higher symptom severity, functional impairment, and lower quality of life. 6

Criterion D: Duration

  • The illness preoccupation must be present for at least 6 months. 4, 3
  • The specific illness feared may change over this 6-month period. 3

Criterion E: Exclusionary Criteria

  • The preoccupation is not better explained by another mental disorder such as Somatic Symptom Disorder, Panic Disorder, Generalized Anxiety Disorder, Body Dysmorphic Disorder, Obsessive-Compulsive Disorder, or Delusional Disorder (somatic type). 3

Specifiers for Care-Seeking Behavior

Care-seeking type: Medical care is frequently utilized. 1

Care-avoidant type: Medical care is rarely utilized. 1

Mixed type: The patient fluctuates between seeking and avoiding care (this is the most common presentation, occurring in 61% of IAD cases). 1

Key Distinction: IAD vs. Somatic Symptom Disorder

The critical differentiator is somatic symptom burden:

  • IAD: Minimal or no somatic symptoms are present; the focus is on anxiety about potentially having a serious illness. 1, 2, 3
  • SSD: Significant somatic symptoms are present and distressing, with excessive thoughts, feelings, or behaviors related to these symptoms. 1, 2, 3

Epidemiological Distribution

  • Among patients with DSM-IV hypochondriasis, approximately 74% meet criteria for SSD and only 26% meet criteria for IAD under DSM-5. 2
  • In health-anxious treatment-seeking samples, 45% meet SSD criteria, 47% meet IAD criteria, and 8% meet both. 1

Clinical Characteristics and Severity Differences

Patients with SSD demonstrate greater clinical severity compared to IAD:

  • Higher health anxiety severity and somatic symptom burden. 1, 2
  • More functional impairment and disability. 1
  • Higher rates of comorbid disorders, particularly Major Depressive Disorder, Panic Disorder, and Agoraphobia. 1, 2
  • Greater healthcare utilization, including more medical and psychologist visits. 1, 5

However, both IAD and SSD share similar core features:

  • Comparable levels of hypochondriacal characteristics, illness behavior, somatic symptom attributions, and physical concerns. 2
  • Similar response to Cognitive Behavioral Therapy (CBT). 2, 5

Diagnostic Reliability

IAD demonstrates excellent diagnostic reliability (kappa = 0.80), superior to DSM-IV hypochondriasis (kappa = 0.60). 1

Common Pitfalls and Clinical Considerations

Cultural Factors

  • Somatic presentations predominate in non-Western cultures, potentially leading to underdiagnosis of IAD when DSM-5's emphasis on psychological worry is applied rigidly. 7
  • Bilingual patients may emphasize somatic complaints in certain languages (e.g., Spanish) versus psychological symptoms in English. 8

Differential Diagnosis Challenges

  • Rule out medical conditions that could explain the health concerns before diagnosing IAD. 3
  • Distinguish from Generalized Anxiety Disorder: In GAD, worry is generalized across multiple life domains; in IAD, worry is specifically focused on health and illness. 8
  • Distinguish from Panic Disorder: In panic disorder, anxiety centers on panic attacks themselves, not on having a serious underlying disease. 1
  • Distinguish from Obsessive-Compulsive Disorder: While both may involve checking behaviors, OCD involves broader obsessions and compulsions beyond health concerns. 7

Personality Pathology

  • Substantial comorbidity exists between personality pathology and IAD, particularly Avoidant and Dependent Personality Disorders. 9
  • Personality traits of negative affectivity, detachment, and psychoticism are associated with greater functional impairment in hypochondriasis. 9

Treatment Implications

  • Cognitive Behavioral Therapy (CBT) is the most effective treatment for IAD, with strong empirical support. 4, 3
  • SSRIs are commonly prescribed medications for health anxiety. 10
  • Poor follow-up rates are common (median 2 months in one study), highlighting the importance of engagement strategies. 10

Ongoing Diagnostic Controversies

The validity of splitting hypochondriasis into IAD and SSD remains debated:

  • Some research suggests the distinction conveys little useful clinical information, as differences appear primarily related to severity rather than distinct pathophysiology. 2, 5
  • The ICD-11 continues to classify hypochondriasis as an anxiety disorder, reflecting ongoing nosological uncertainty. 7
  • Research using DSM-5 IAD criteria is still limited, and more validation studies are needed. 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.